Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 11/20 | 0.67 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.57 |
| ▸ | ALB | P02768 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7573859 | 0.86 | TSPO (0.69) | TSPOOPRK1ALB | |
| SCHEMBL14542056 | 0.85 | TSPO (0.67) | TSPOOPRK1ALB | |
| SCHEMBL2757574 | 0.85 | TSPO (0.70) | TSPOOPRK1ALB | |
| SCHEMBL7575533 | 0.85 | TSPO (0.82) | TSPOOPRK1ALB | |
| SCHEMBL14542291 | 0.85 | TSPO (0.77) | TSPOOPRK1ALB | |
| SCHEMBL7574173 | 0.84 | TSPO (0.69) | TSPOOPRK1ALB | |
| Ammonia Solution, Strong SCHEMBL7569838 | 0.84 | TSPO (0.75) | TSPOOPRK1ALB | |
| SCHEMBL7574707 | 0.84 | TSPO (0.80) | TSPOOPRK1ALB | |
| SCHEMBL2757581 | 0.84 | TSPO (0.69) | TSPOOPRK1ALB | |
| SCHEMBL7566742 | 0.81 | TSPO (0.66) | TSPOOPRK1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6476056-B2 | ANTIINFLAMMATORY AGENTS, PSYCHOLOGICAL DISORDERS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| EP-1004573-B1 | ARYLOXYANILINE DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2002-10-30 | — | — | EP | disclosed |
| US-20020147191-A1 | Aryloxyaniline derivatives | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-10-10 | — | — | US | disclosed |
| US-6333358-B1 | AMIDE DERIVATIVES OF ANILINE AS ANTIDEPRESSANTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| CN-1265642-A | Aryloxyaniline derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2000-09-06 | — | — | CN | disclosed |
| EP-1004573-A1 | ARYLOXYANILINE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147191-A1 | Aryloxyaniline derivatives | FPR2, ARG2, CYP11B2 | TSPO 1248/4885OPRK1 89/4885ALB 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.